PARLIAMENTARY WRITTEN QUESTION
Multiple Sclerosis: Drugs (9 February 2016)
Question Asked
Asked by:
Nick Thomas-Symonds (Labour)
Answer
The Department is currently discussing with key stakeholders the arrangements for formally bringing the Multiple Sclerosis Risk Sharing Scheme to an end. Patients currently receiving drugs as part of the Scheme will continue to do so for as long as this is clinically appropriate for them.
Answered by:
George Freeman (Conservative)
22 February 2016
Contains Parliamentary information licensed under the Open Parliament Licence v3.0.